Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase 1 study of AX-0810 in healthy volunteers, with initial safety, tolerabilit ...

Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase ...

US-based medicine company Eli Lilly to invest $3B in a new manufacturing facility in the Netherlands to expand production and ...

BMW yesterday reported rising profitability in the last quarter despite slowing Chinese sales and the impact of tariffs, ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly and Company's US$3bn manufacturing site in the Netherlands is set to create around 1,500 construction jobs during ...

IHE just hit a 52-week high. The ETF is up nearly 30% from its low, powered by $LLY's 9.6% past week surge and bold expansion plans. More upside ahead?

Heineken’s Harold van den Broek said beer demand remains soft, Tesla’s Vaibhav Taneja flagged tariff drag, Brian Dykes talked ...

Eli Lilly stock recently achieved a significant milestone, reaching a 52-week high of $935.68, with shares now trading at $935.97. This marks a notable achievement for the pharmaceutical giant, ...

In a bid to boost oral medicine manufacturing capacity in Europe for patients worldwide, Lilly has confirmed plans to invest ...

Market observers are closely monitoring potential developments in discussions between Eli Lilly and the Trump administration. Reports indicate the company may be nearing a landmark agreement that ...

Comments from medicines firm Eli Lilly will be a blow to British officials, who are in advanced negotiations with the Trump ...